AIM: To investigate mechanisms by which doxorubicin (DOX) and cisplatin (CIS) cause human ovarian stroma injury. PATIENTS & METHODS: Stromal cells from human cryopreserved ovarian tissue were cultured in the presence of 1 µM DOX and 10 µM CIS. Ovarian damage induced by treatments was evaluated by 'Live/Dead' and sulforhodamine-B assays, the expression of different apoptosis markers. RESULTS: Stromal cell growth was inhibited by DOX and CIS, and this effect was accompanied by apoptosis through mitochondrial pathway activation: Bax, cleaved-caspase 9, cleaved-PARP1 induction and Akt1, Bcl2, phospho-44/42-MAPK/ERK1/2 reduction were observed. CONCLUSION: DOX and CIS induced apoptosis in human ovarian stromal cells. Knowledge of mechanism...
<div><p>Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemothera...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
Background: Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for ...
AIM: To investigate mechanisms by which doxorubicin (DOX) and cisplatin (CIS) cause human ovarian s...
<div><p>Purpose</p><p>Chemotherapy treatment in premenopausal women has been linked to ovarian folli...
Chemotherapy treatment in premenopausal women has been linked to ovarian follicle loss and premature...
The mechanism of chemotherapy-induced acceleration of ovarian aging is not fully understood. We used...
In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on...
<p><b>A.</b> Dose-dependent effects of cisplatin in ovarian cell lines. Cells were exposed to cispla...
Abstract Background Young cancer patients may occasionally face infertility and premature gonadal fa...
Chemotherapy treatment in premenopausal women has been linked to premature ovarian failure (POF), a...
Cancer therapies often lead to premature ovarian insufficiency by ovarian damage and follicle deplet...
The cytotoxicity of Cisplatin (CDDP) is traditionally believed to be cell cycle independent. This ge...
BACKGROUND: Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility ...
Abstract There is a controversy in literature as to whether c-Abl is crucial for the induction of TA...
<div><p>Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemothera...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
Background: Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for ...
AIM: To investigate mechanisms by which doxorubicin (DOX) and cisplatin (CIS) cause human ovarian s...
<div><p>Purpose</p><p>Chemotherapy treatment in premenopausal women has been linked to ovarian folli...
Chemotherapy treatment in premenopausal women has been linked to ovarian follicle loss and premature...
The mechanism of chemotherapy-induced acceleration of ovarian aging is not fully understood. We used...
In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on...
<p><b>A.</b> Dose-dependent effects of cisplatin in ovarian cell lines. Cells were exposed to cispla...
Abstract Background Young cancer patients may occasionally face infertility and premature gonadal fa...
Chemotherapy treatment in premenopausal women has been linked to premature ovarian failure (POF), a...
Cancer therapies often lead to premature ovarian insufficiency by ovarian damage and follicle deplet...
The cytotoxicity of Cisplatin (CDDP) is traditionally believed to be cell cycle independent. This ge...
BACKGROUND: Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility ...
Abstract There is a controversy in literature as to whether c-Abl is crucial for the induction of TA...
<div><p>Primary ovarian insufficiency (POI) is one of the many unintended consequences of chemothera...
The aim of our study was to determine the effect of selected cytostatics on a human ovarian cancer c...
Background: Detecting a new effective and hypotoxic anticancer drug is an emerging new strategy for ...